AOD-9604 is one of those subjects where the details matter more than the headlines. This page pulls together the background, the mechanisms, and the practical points readers ask about most.
Last reviewed on 2025-08-12. Where a claim depends on a specific study, the study is described rather than over-claimed.
AOD-9604 is a synthetic peptide whose sequence is modeled on the C-terminal region of human growth hormone. Published descriptions commonly place it as a modified fragment corresponding to hGH amino acids 176–191, with a tyrosine residue added or retained at the N-terminus to support detection and handling. It is not intact growth hormone and lacks the full receptor-binding architecture of the parent protein. The molecule was developed as a research candidate for metabolic studies rather than as a replacement for growth hormone therapy. Its identity is defined by its amino acid sequence rather than by any single commercial preparation.
AOD-9604 drew attention in the 1990s and 2000s as a potential anti-obesity agent. Early work explored both injectable and oral routes, which is unusual for a peptide of this size. Animal studies reported changes in fat metabolism without the growth-promoting or insulin-like effects associated with full-length growth hormone. Subsequent human trials produced mixed or modest results, and the compound did not obtain regulatory approval for weight management in major markets. It remains known mainly through research literature, sports anti-doping listings, and non-approved supplement advertising.
AOD-9604 is prohibited in sport by the World Anti-Doping Agency under the peptide hormone class. Its presence in a sample can be detected through mass spectrometry-based methods, although the exact assay depends on the laboratory. In research settings, material is often supplied as a lyophilized powder for reconstitution. Buyers and researchers should note that products labeled AOD-9604 may vary in purity and actual peptide content. Analytical certificates and independent testing are common ways to verify identity, but no global harmonized standard exists for all commercial lots.
Stability of AOD-9604 depends on storage conditions. Lyophilized powder is generally more stable than reconstituted solution. Recommended storage is typically at -20°C or lower, protected from light and moisture. Repeated freeze-thaw cycles can cause aggregation or degradation. In solution, the peptide may be susceptible to hydrolysis or oxidation, so aliquoting and cold storage are common practices. Researchers often add stabilizers such as mannitol or trehalose during lyophilization to improve shelf life.
Quality control for AOD-9604 involves verifying identity, purity, and concentration. Suppliers may provide a certificate of analysis listing HPLC purity and mass spectrometry data. Independent verification is advised because peptide products can vary in quality. Researchers should check for counterions, residual solvents, and microbial contamination. Proper documentation supports reproducibility and safety in laboratory studies. When sourcing, institutions often require third-party testing and detailed chain-of-custody records. These steps help ensure that experimental results are attributable to the peptide rather than impurities.
| Property | Value | Notes |
|---|---|---|
| Molecular class | Synthetic peptide | Fragment analog of human growth hormone |
| Sequence basis | hGH 176–191 region | Modified C-terminal fragment |
| Common synonyms | AOD-9604; AOD9604; hGH fragment | Research and trade names vary |
| Regulatory status | Not approved as a drug | Prohibited in competitive sport |
| Research code | AOD9604 | Used in scientific and patent literature |
AOD-9604 is a synthetic peptide modeled on the C-terminal region of human growth hormone. It corresponds to residues 176-191 of the 191-amino-acid hGH sequence. The fragment is not the full hormone and lacks the receptor-binding region associated with growth and metabolic effects of hGH. Researchers developed it to isolate a specific portion of hGH for study. Its exact sequence and length are often stated in peptide catalogs and patents.
The peptide is frequently described as a growth hormone fragment, although it is chemically distinct from full-length hGH. AOD-9604 contains 16 amino acids and includes two cysteine residues that can form an intramolecular disulfide bond. In solution, this structural feature can influence folding, aggregation, and stability. Published descriptions sometimes call it hGH 176-191 or AOD9604, with spacing and capitalization varying. Such naming differences can complicate literature searches, database entries, and product verification.
Researchers have studied the fragment in cell and animal models to understand its metabolic actions. Some experiments report effects on fat breakdown and fat storage pathways, but the underlying mechanism remains incompletely defined. AOD-9604 does not appear to stimulate the same broad growth hormone receptor signaling as full-length hGH. Whether its observed activities arise from direct receptor interactions or downstream metabolic changes is an open question. Results from different assays are not always consistent.
AOD-9604 is a synthetic peptide whose structure corresponds to a C-terminal segment of human growth hormone. It is often described as hGH fragment 176-191, a 16-amino-acid sequence. The peptide was designed to isolate a region of hGH associated with fat metabolism while avoiding the full hormone's growth-promoting actions. Laboratory and commercial materials typically present it as a lyophilized powder for research use. Its identity is defined by amino acid sequence, not by a single brand.
The fragment includes residues that can form an internal disulfide bond between two cysteine positions. This structural feature can influence how the peptide folds and how stable it is in solution. AOD-9604 differs from full-length hGH in size and receptor interactions; it does not contain the entire growth hormone sequence. Published descriptions sometimes use slightly different residue numbering, so sequence information should be checked against primary sources. The molecule is small compared with intact hGH, which affects analytical detection and purification approaches.
Interest in AOD-9604 arose from attempts to separate metabolic effects from growth effects attributed to hGH. Early work explored whether the fragment could influence lipolysis or fat oxidation without promoting growth. Those questions remain partly unresolved because human data are limited and results have varied across studies. The peptide is not a hormone replacement for hGH and is not equivalent to hGH in clinical use. Its research history includes both laboratory studies and commercial marketing claims that are not the same as regulatory approval.
The compound has been studied as a potential treatment for obesity and related metabolic conditions. Published trials have examined changes in body weight, fat mass, and safety markers over limited durations. Results have been mixed or modest, and no large-scale outcome trials are established. Regulatory agencies in several countries have not approved it as a therapeutic drug. Some commercial products have been marketed outside regulated pharmaceutical channels, which raises questions about quality and claims.
In the scientific literature, AOD-9604 appears in reviews of growth hormone fragments and in discussions of peptide-based metabolic research. Some sources distinguish it from growth hormone itself, while others group it with compounds marketed for weight management. The evidence base is small compared with approved obesity medications. Questions about long-term efficacy and clinical relevance remain open, and independent replication of key findings is limited. Most published reports are early-stage and exploratory.
Absorption spectroscopy techniques (e.g., FTIR, ultraviolet-visible ("UV-vis") spectroscopy) measure how much light a sample absorbs at each wavelength. The most straightforward way to do this, the "dispersive spectroscopy" technique, is to shine a monochromatic light beam at a sample, measure how much of the light is absorbed, and repeat for each different wavelength. The dispersive spectroscopy technique is used by some UV–vis spectrometers to take measurements. Fourier transform spectroscopy is a less intuitive way to obtain the same information. Rather than shining a monochromatic beam of light (a beam composed of only a single wavelength) at the sample, this technique shines a beam containing many frequencies of light at once and measures how much of that beam is absorbed by the sample. Next, the beam is modified to contain a different combination of frequencies, giving a second data point. This process is rapidly repeated many times over a short time span. Afterwards, a computer takes all this data and works backward to infer what the absorption is at each wavelength. The beam described above is generated by starting with a broadband light source—one containing the full spectrum of wavelengths to be measured. The light shines into a Michelson interferometer—a certain configuration of mirrors, one of which is moved by a motor. As this mirror moves, each wavelength of light in the beam is periodically blocked, transmitted, blocked, transmitted, by the interferometer, due to wave interference.
== Plot == An expedition discovered a derelict alien reconnaissance spaceship, which turned out to be fully automated and run by robots. Doctor Pavlysh, a member of the team, accidentally discovers scattered notes written in Russian. It turns out that these were the diary of a Soviet woman, Nadezhda Matveyevna Sidorova. In 1956, she was abducted by this spaceship, whose mission was to collect biological specimens all over the universe, and she has become a living exhibit on the spaceship. Her diary covers the long second half of her life, hence the title of the novel. Nadezhda, the only human occupant, was able to communicate with other captured intelligent non-humanoid species, whom she calls "trepangs" due to their appearance. Together, they organize an escape from the vessel, but Nadezhda Sidorova tragically dies while distracting the guards, allowing the others to escape. Humans later learned that there is a monument to Nadezhda Sidorova at the native planet of the "trepangs", whose memry is cherished there.
==== Microsomal triglyceride transfer protein (MTTP) ==== Microsomal triglyceride transfer protein (MTTP) is an endoplasmic reticulum lipid transfer protein involved in the biosynthesis and lipid loading of apolipoprotein B. MTTP is also involved in the late stage of CD1d trafficking in the lysosomal compartment, CD1d being the MHC I-like lipid antigen presenting molecule.
==== Roman Empire ==== Although the Iapydes plundered Aquileia during the Augustan period, subsequent increased settlement and no lack of profitable work meant the city was able to develop its resources. Jewish artisans established a flourishing trade in glass-work. Metal from Noricum was forged and exported. The ancient Venetic trade in amber from the Baltic continued. Wine, especially its famous Pucinum was exported. Olive oil was imported from Proconsular Africa. By sea, the port of Aquae Gradatae (modern Grado) was developed. On land, Aquileia was the starting-point of several important roads leading outside Italy to the north-eastern portion of the empire — the road (Via Julia Augusta) by Iulium Carnicum (Zuglio) to Veldidena (mod. Wilten, near Innsbruck), from which branched off the road into Noricum, leading by Virunum (Klagenfurt) to Laurieum (Lorch) on the Danube, the road leading via Emona into Pannonia and to Sirmium (Sremska Mitrovica), the road to Tarsatica (near Fiume, now Rijeka) and Siscia (Sisak), and the road to Tergeste (Trieste) and the Istrian coast. Augustus was the first of a number of emperors to visit Aquileia, notably during the Pannonian wars in 12–10 BC. It was the birthplace of Tiberius' son by Julia, in the latter year. The Roman poet Martial praised Aquileia as his hoped-for haven and resting place in his old age. In terms of religion, the populace adopted the Roman pantheon, although the Celtic sun-god, Belenus, had a large following. Jews practiced their ancestral religion. Meanwhile, soldiers brought the martial cult of Mithras.
Sources: en.wikipedia.org
== Differential diagnosis == The presentation of some cases is similar to that of Kearns–Sayre syndrome. Myoclonus epilepsy associated with ragged red fibers (MERRF) may be confused with MELAS as they both involve seizures, mental deterioration, and myopathy with ragged red fibers on biopsy. MERRF patients may also have hearing loss, visual disturbance secondary to optic atrophy, and short stature. The characteristic myoclonic seizure in MERRF may help to narrow diagnosis, but genetic testing should be considered to distinguish the two conditions. Leigh syndrome may also present with progressive neurological deterioration, seizures, and vomiting, mainly in young children.
Tobacco and Americans (McGraw-Hill, 1960) online Hilton, Matthew, Smoking in British Popular Culture, 1800–2000 (Manchester University Press, 2000) Hirschfelder, Arlene B. Encyclopedia of smoking and tobacco (1999) online Kellner, Irwin L. "THE AMERICAN CIGARETTE INDUSTRY: A RE-EXAMINATION" (PhD dissertation, New School for Social Research, 1973; ProQuest Dissertations Publishing, 1973. 7400153). Klein, Richard. Cigarettes are Sublime (Duke University Press, 1993) the meaning of cigarettes in literature, films, war, ads, & sex. online Kluger, Richard. Ashes to Ashes: America's Hundred-Year Cigarette War, the Public Health, and the Unabashed Triumph of Philip Morris (Vintage, 1997). excerpt Milov, Sarah. The Cigarette: A Political History (Harvard University Press. 2019) Oreskes, Naomi, and Erik M. Conway. Merchants of doubt: How a handful of scientists obscured the truth on issues from tobacco smoke to global warming (Bloomsbury Publishing USA, 2011). Parker-Pope, Tara. Cigarettes: Anatomy of an Industry from Seed to Smoke (2002) online Porter, Patrick G. "Origins of the American Tobacco Company." Business History Review 43.1 (1969): 59–76. online Porter, Patrick G. "Advertising in the early cigarette industry: W. Duke, Sons & Company of Durham." North Carolina Historical Review 48.1 (1971): 31–43. Robert, Joseph C. The Story of Tobacco in America (1959), by a scholar. online Robinson, Daniel J. Cigarette Nation: Business, Health, and Canadian Smokers, 1930-1975 (McGill-Queen's University Press, 2021) Rothfeder, Jeffrey. The People vs.
=== Run-to-waste === In a run-to-waste system, nutrient and water solution is periodically applied to the medium surface. The method was invented in Bengal in 1946; for this reason it is sometimes referred to as "The Bengal System".
Sources: en.wikipedia.org
The lily family, Liliaceae, consists of about 15 genera and 610 species of flowering plants within the order Liliales. They are monocotyledonous, perennial, herbaceous geophytes, often growing from bulbs although some have rhizomes. The leaves are linear in shape, with their veins usually arranged parallel to the edges, single and arranged alternating on the stem, or in a rosette at the base. The flowers are large with six colored or patterned petaloid tepals (undifferentiated petals and sepals) arranged in two whorls of three, six stamens and a superior ovary. The fruit can be a berry or capsule, with seeds dispersed by animals or wind, respectively. First described in 1789, the lily family became a paraphyletic "catch-all" (wastebasket) group of lilioid monocots that did not fit into other families and included many genera now included in other families (and in some cases in other orders). Consequently, treatments of "Liliaceae" often include these other taxa. The family likely evolved between 82 and 52 million years ago during the Late Cretaceous to Early Paleogene periods. Plants in this family have evolved with a fair amount of morphological diversity despite their genetic similarity. Liliaceae are widely distributed, mainly in temperate regions of the Northern Hemisphere and the flowers are insect pollinated. Most of their genera, Lilium in particular, face considerable herbivory pressure from deer in some areas, both wild and domestic.
== Rhabdomyolysis == Exertional rhabdomyolysis is an extreme and potentially deadly form of overtraining that leads to a breakdown of skeletal muscle which makes its way into the blood. Many molecules such as potassium, creatine kinase, phosphate, and myoglobin are released into circulation. Myoglobin is the protein that causes the lethal reaction in the body. Early detection of the syndrome is essential in full recovery. A serious late complication of rhabdomyolysis which occurs in 15% of the population is acute kidney injury, and in some cases it can lead to death.
==== 2700–2799 ==== Social Security (Introduction of Disability Living Allowance) (Amendment) (No. 3) Regulations 1993 (S.I. 1993/2704) Capital Allowances (Corresponding Northern Ireland Grants) Order 1993 (S.I. 1993/2705) Building Societies (Designation of Qualifying Bodies) (No. 3) Order 1993 (S.I. 1993/2706) Education (No. 2) Act 1986 (Amendment) Order 1993 (S.I. 1993/2709) Housing Renovation etc. Grants (Grant Limit) (Amendment) Order 1993 (S.I. 1993/2711) Reconstitution of the River Ouzel Internal Drainage Board Order 1993 (S.I. 1993/2712) Placing on the Market and Supervision of Transfers of Explosives Regulations 1993 (S.I. 1993/2714) Food Labelling (Scotland) Amendment Regulations 1993 (S.I. 1993/2731) Teachers (Education, Training and Recommendation for Registration) (Scotland) Regulations 1993 (S.I. 1993/2732) Portsmouth Mile End Quay (Berth No. 2 Extension) Harbour Revision Order 1993 (S.I. 1993/2733) Criminal Justice Act 1993 (Commencement No. 3) Order 1993 (S.I. 1993/2734) Social Security (Contributions) (Miscellaneous Amendments) Regulations 1993 (S.I. 1993/2736) Public Service Vehicles (Registration of Local Services) (Amendment) Regulations 1993 (S.I. 1993/2752) Public Service Vehicles (Operators' Licences) (Amendment) Regulations 1993 (S.I. 1993/2753) Public Service Vehicles (Traffic Commissioners: Publication and Inquiries) (Amendment) Regulations 1993 (S.I. 1993/2754) Copyright (Certification of Licensing Scheme for Educational Recording of Broadcasts) (Open University Educational Enterprises Limited) Order 1993 (S.I.
Sources: en.wikipedia.org
No. It is a synthetic peptide fragment modeled on part of human growth hormone, not the full hormone. It does not contain the complete sequence or receptor-binding regions of hGH.
It was investigated in clinical trials for obesity, but it did not receive approval for that use in major markets. Results were generally modest or mixed, and it remains an experimental compound.
WADA lists it as a prohibited peptide hormone. Its use can be detected by laboratory methods, and athletes are subject to sanctions if it is found in samples.
Reversed-phase HPLC is used to assess purity, and mass spectrometry confirms molecular mass. Amino acid analysis can verify composition. These methods are standard for peptide characterization.